Mechanism and spectrum of inhibition of a 4′-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses DOI Creative Commons
Calvin J. Gordon, Simon Walker, Egor P. Tchesnokov

et al.

Journal of Biological Chemistry, Journal Year: 2024, Volume and Issue: 300(8), P. 107514 - 107514

Published: June 28, 2024

The development of safe and effective broad-spectrum antivirals that target the replication machinery respiratory viruses is high priority in pandemic preparedness programs. Here, we studied mechanism action a newly discovered nucleotide analog against diverse RNA-dependent RNA polymerases (RdRps) prototypic viruses. GS-646939 active 5'-triphosphate metabolite 4'-cyano modified C-adenosine phosphoramidate prodrug GS-7682. Enzyme kinetics show RdRps human rhinovirus type 16 (HRV-16) enterovirus 71 incorporate with unprecedented selectivity; incorporated 20-50-fold more efficiently than its natural ATP counterpart. RdRp complex syncytial virus metapneumovirus similar efficiency. In contrast, influenza B shows clear preference for mitochondrial polymerase does not significant incorporation GS-646939. Once into nascent strand, acts as chain terminator although higher NTP concentrations can partially overcome inhibition some polymerases. Modeling biochemical data suggest 4'-modification inhibits translocation. Comparative studies GS-443902, triphosphate form 1'-cyano prodrugs remdesivir obeldesivir, reveal only different mechanisms inhibition, but also differences spectrum viral conclusion, modifications analogs provide complementary strategies to several families

Language: Английский

No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials DOI Creative Commons
Charlotte Hedskog, Christoph D. Spinner, Ulrike Protzer

et al.

Viruses, Journal Year: 2024, Volume and Issue: 16(4), P. 546 - 546

Published: March 31, 2024

Remdesivir (RDV) is a broad-spectrum nucleotide analog prodrug approved for the treatment of COVID-19 in hospitalized and non-hospitalized patients with clinical benefit demonstrated multiple Phase 3 trials. Here we present SARS-CoV-2 resistance analyses from SIMPLE studies evaluating RDV participants severe or moderate disease. The enrolled radiologic evidence pneumonia room-air oxygen saturation ≤94% >94%, respectively. Virology sample collection was optional study protocols. Sequencing related viral load data were obtained retrospectively at subset sites local sequencing capabilities (10 183 sites) timepoints detectable load. Among both baseline post-baseline treated RDV, emergent Nsp12 substitutions observed 4 19 (21%) none 2 study. following 5 emerged: T76I, A526V, A554V, E665K, C697F. C697F had an EC50 fold change ≤1.5 relative to wildtype reference using subgenomic replicon system, indicating no significant susceptibility RDV. phenotyping E665K could not be determined due lack replication. These reveal relevant emergence further confirm established efficacy profile high barrier patients.

Language: Английский

Citations

3

Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase DOI
Tiantian Xu, Lu Zhang

Computational and Structural Biotechnology Journal, Journal Year: 2023, Volume and Issue: 21, P. 4385 - 4394

Published: Jan. 1, 2023

Language: Английский

Citations

8

Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy DOI Creative Commons
Annelies Stevaert, Elisabetta Groaz, Lieve Naesens

et al.

Current Opinion in Virology, Journal Year: 2022, Volume and Issue: 57, P. 101279 - 101279

Published: Nov. 17, 2022

Language: Английский

Citations

12

Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains DOI
Heiko Slanina, Ramakanth Madhugiri,

Kai Wenk

et al.

Journal of Virology, Journal Year: 2023, Volume and Issue: 97(6)

Published: May 18, 2023

Coronavirus genome replication and expression are mediated by the viral replication-transcription complex (RTC) which is assembled from multiple nonstructural proteins (nsp). Among these, nsp12 represents central functional subunit. It harbors RNA-directed RNA polymerase (RdRp) domain contains, at its N terminus, an additional called NiRAN widely conserved in coronaviruses other nidoviruses. In this study, we produced bacterially expressed coronavirus nsp12s to investigate compare NiRAN-mediated NMPylation activities representative alpha- betacoronaviruses. We found that four domains characterized date have a number of properties, including (i) robust nsp9-specific appear operate largely independently C-terminal RdRp domain, (ii) nucleotide substrate preference for UTP followed ATP nucleotides, (iii) dependence on divalent metal ions, with Mn2+ being preferred over Mg2+, (iv) key role N-terminal residues (particularly Asn2) nsp9 efficient formation covalent phosphoramidate bond between NMP amino group nsp9. context, mutational analysis confirmed conservation critical Asn2 across different subfamilies family Coronaviridae, as shown studies using chimeric variants six were replaced those corona-, pito- letovirus homologs. The combined data previous reveal remarkable degree among activities, supporting enzymatic activity synthesis processing. IMPORTANCE There strong evidence large nidoviruses evolved unique RdRp-associated but not most viruses. Previous mainly focused severe acute respiratory syndrome 2 (SARS-CoV-2) suggested functions such NMPylation/RNAylation nsp9, guanylyltransferase involved canonical and/or unconventional capping pathways, functions. To help resolve partly conflicting information specificities ion requirements reported previously SARS-CoV-2 activity, extended these earlier characterizing betacoronavirus domains. study revealed features protein specificity requirements, very well genetically divergent coronaviruses, suggesting potential avenues future antiviral drug development targeting essential enzyme.

Language: Английский

Citations

7

Mechanism and spectrum of inhibition of a 4′-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses DOI Creative Commons
Calvin J. Gordon, Simon Walker, Egor P. Tchesnokov

et al.

Journal of Biological Chemistry, Journal Year: 2024, Volume and Issue: 300(8), P. 107514 - 107514

Published: June 28, 2024

The development of safe and effective broad-spectrum antivirals that target the replication machinery respiratory viruses is high priority in pandemic preparedness programs. Here, we studied mechanism action a newly discovered nucleotide analog against diverse RNA-dependent RNA polymerases (RdRps) prototypic viruses. GS-646939 active 5'-triphosphate metabolite 4'-cyano modified C-adenosine phosphoramidate prodrug GS-7682. Enzyme kinetics show RdRps human rhinovirus type 16 (HRV-16) enterovirus 71 incorporate with unprecedented selectivity; incorporated 20-50-fold more efficiently than its natural ATP counterpart. RdRp complex syncytial virus metapneumovirus similar efficiency. In contrast, influenza B shows clear preference for mitochondrial polymerase does not significant incorporation GS-646939. Once into nascent strand, acts as chain terminator although higher NTP concentrations can partially overcome inhibition some polymerases. Modeling biochemical data suggest 4'-modification inhibits translocation. Comparative studies GS-443902, triphosphate form 1'-cyano prodrugs remdesivir obeldesivir, reveal only different mechanisms inhibition, but also differences spectrum viral conclusion, modifications analogs provide complementary strategies to several families

Language: Английский

Citations

2